BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33019389)

  • 1. Red blood cells function as reservoirs of tumor DNA.
    Thompson JC; Li S; Jose JS; Predina J; Gupta A; Eruslanov E; Singhal S; Albelda SM; Mangalmurti NS
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L646-L650. PubMed ID: 38529551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in plasma.
    Wang L; Wen X; Yang Y; Hu Z; Jiang J; Duan L; Liao X; He Y; Liu Y; Wang J; Liang Z; Zhu X; Liu Q; Liu T; Luo D
    Commun Biol; 2024 May; 7(1):657. PubMed ID: 38806596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis.
    Chen C; Douglas MP; Ragavan MV; Phillips KA; Jansen JP
    medRxiv; 2023 Oct; ():. PubMed ID: 37961510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis.
    Borg M; Wen SWC; Andersen RF; Timm S; Hansen TF; Hilberg O
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in non-small cell lung cancer: a meta-analysis of state-of-the-art and future perspectives.
    Franzi S; Seresini G; Borella P; Raviele PR; Bonitta G; Croci GA; Bareggi C; Tosi D; Nosotti M; Tabano S
    Front Genet; 2023; 14():1254839. PubMed ID: 38116291
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
    Nakamura Y; Taniguchi H; Ikeda M; Bando H; Kato K; Morizane C; Esaki T; Komatsu Y; Kawamoto Y; Takahashi N; Ueno M; Kagawa Y; Nishina T; Kato T; Yamamoto Y; Furuse J; Denda T; Kawakami H; Oki E; Nakajima T; Nishida N; Yamaguchi K; Yasui H; Goto M; Matsuhashi N; Ohtsubo K; Yamazaki K; Tsuji A; Okamoto W; Tsuchihara K; Yamanaka T; Miki I; Sakamoto Y; Ichiki H; Hata M; Yamashita R; Ohtsu A; Odegaard JI; Yoshino T
    Nat Med; 2020 Dec; 26(12):1859-1864. PubMed ID: 33020649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of
    Goldberg SB; Redman MW; Lilenbaum R; Politi K; Stinchcombe TE; Horn L; Chen EH; Mashru SH; Gettinger SN; Melnick MA; Herbst RS; Baumgart MA; Miao J; Moon J; Kelly K; Gandara DR
    J Clin Oncol; 2020 Dec; 38(34):4076-4085. PubMed ID: 33021871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Sebastião MM; Ho RS; de Carvalho JPV; Nussbaum M
    J Health Econ Outcomes Res; 2020; 7(2):158-163. PubMed ID: 33043062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding EGFR heterogeneity in lung cancer.
    Passaro A; Malapelle U; Del Re M; Attili I; Russo A; Guerini-Rocco E; Fumagalli C; Pisapia P; Pepe F; De Luca C; Cucchiara F; Troncone G; Danesi R; Spaggiari L; De Marinis F; Rolfo C
    ESMO Open; 2020 Oct; 5(5):e000919. PubMed ID: 33067323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive
    Yu HA; Paz-Ares LG; Yang JC; Lee KH; Garrido P; Park K; Kim JH; Lee DH; Mao H; Wijayawardana SR; Gao L; Hozak RR; Chao BH; Planchard D
    Clin Cancer Res; 2021 Feb; 27(4):992-1002. PubMed ID: 33046516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications.
    Yu M; Ji W; Yang X; Tian K; Ma X; Yu S; Chen L; Zhao X
    Front Immunol; 2023; 14():1279735. PubMed ID: 38094306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review.
    Nigro MC; Marchese PV; Deiana C; Casadio C; Galvani L; Di Federico A; De Giglio A
    Lung Cancer (Auckl); 2023; 14():11-25. PubMed ID: 36762267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application Value of Serum Multi-Antibody Combined Detection in Differential Diagnosis and Typing of Lung Cancer.
    Cai T; Yao W; Liang F; Yang Q; Han F
    J Oncol; 2022; 2022():8944263. PubMed ID: 35126518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients.
    Liu L; Xiong X
    Curr Oncol; 2021 Dec; 29(1):77-93. PubMed ID: 35049681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management.
    Fernandes MGO; Cruz-Martins N; Machado JC; Costa JL; Hespanhol V
    Cancer Cell Int; 2021 Dec; 21(1):675. PubMed ID: 34915883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study.
    Ačkar L; Casjens S; Andreas A; Raiko I; Brüning T; Geffken M; Peine S; Kollmeier J; Johnen G; Bartkowiak K; Weber DG; Pantel K
    Mol Oncol; 2021 Nov; 15(11):2877-2890. PubMed ID: 34510714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer.
    Nagasaka M; Uddin MH; Al-Hallak MN; Rahman S; Balasubramanian S; Sukari A; Azmi AS
    Mol Cancer; 2021 Jun; 20(1):82. PubMed ID: 34074295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer: A PRISMA-compliant meta-analysis and systematic review.
    Zhou S; Huang R; Cao Y
    Medicine (Baltimore); 2020 Oct; 99(40):e21965. PubMed ID: 33019389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.